OUR VISION
TToP aims at
improving the effectiveness of preclinical prediction
of human responses to drugs reducing costly failures in clinical trials and minimizing the controversial use of animal models.
TToP aims at
of human responses to drugs reducing costly failures in clinical trials and minimizing the controversial use of animal models.
is a Biomedical Engineering PhD student at Politecnico di Milano. He is expert in rapid prototyping techniques, and he is also interested in the startup environment. He attended the Startup Program of the MIP University, and he will hold the CEO role in the early phase of the start-up.
is an 8 years’ experience medical biotechnologist. Her expertise concerns cell and tissue cultures and molecular biology. She is fascinated in the development of new technologies approach for patho-physiological studies. She will hold the CTO role in the early phase of the start-up.
is an associate professor at Politecnico di Milano, holding courses related to cardiovascular biomechanics and technologies for regenerative medicine. He is author of >110 scientific papers in international journals.
is a senior scientist at the Myocardial Disease and Atherosclerosis Unit at San Raffaele scientific institute. She is an expert of 2D/3D models for vascular tissue culture and cell biology, techniques for histology, confocal/electron microscopy, for protein biochemistry and molecular biology (mRNAs and non-coding RNAs), and for ex-vivo imaging.
is the R&D Manager at Qura S.r.L. and in 2013 he obtained a PhD in Biomedical Engineering. He is expert in the design, development and prototyping of mechanical components for cell culture systems, as well as industrialization processes.